CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Estrone

雌酮 杂质对照品Estrone Impurities

29 个杂质条目29 impurity entries

本页汇总 雌酮 的 29 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 29 impurity reference standards of Estrone. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 雌酮(Estrone)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesEstrone degradation: does organic matter (quality), matter?
    Environmental science & technology · 2015 · Tan DT et al.  ·  PMID 25454582  ·  DOI
  2. 杂质研究Impurity studiesSimultaneous Degradation of Estrone, 17β-Estradiol and 17α-Ethinyl Estradiol in an Aqueous UV/H₂O₂ System
    International journal of environmental research and public health · 2015 · Ma X et al.  ·  PMID 26404330  ·  DOI
  3. 分析方法Analytical MethodsDevelopment and validation of a liquid chromatography coupled to mass spectrometer (LC-MS) method for the simultaneous quantification of estrone-3-sulfate, progesterone, estrone and estradiol in serum of mares and American bisons
    Research in veterinary science · 2021 · Dufour P et al.  ·  PMID 33770524  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisA simple and convenient synthesis of 2-methoxyestradiol from estrone
    Steroids · 2012 · Prakasham AP et al.  ·  PMID 22266333  ·  DOI
  • 合成方法SynthesisConversion of Torgov's synthesis of estrone into a highly enantioselective and efficient process
    Journal of the American Chemical Society · 2007 · Yeung YY et al.  ·  PMID 17672468  ·  DOI

雌酮 —— 原料药与杂质对照品Estrone — drug substance & impurities

共 30 个条目(含原料药本体)30 items incl. the drug substance
Estrone structure
原料药 APIAPI
雌酮Estrone
Estrone
CAS No.53-16-7
Chemical FormulaC18H22O2
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 2 structure
2
雌酮杂质2Estrone Impurity 2
Estrone Impurity 2
CAS No.4011-48-7
Chemical FormulaC19H24O2
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 3 structure
3
雌酮杂质3Estrone Impurity 3
Estrone Impurity 3
CAS No.362-08-3
Chemical FormulaC19H24O3
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 4 structure
4
雌酮杂质4Estrone Impurity 4
Estrone Impurity 4
CAS No.30903-07-2
Chemical FormulaC21H26O3
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 5 structure
5
雌酮杂质5Estrone Impurity 5
Estrone Impurity 5
CAS No.105663-60-3
Chemical FormulaC19H26N2O
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 6 structure
6
雌酮杂质6Estrone Impurity 6
Estrone Impurity 6
CAS No.1624-62-0
Chemical FormulaC19H24O2
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 7 Potassium structure
7
雌酮杂质7 钾盐Estrone Impurity 7 Potassium
Estrone Impurity 7 Potassium
CAS No.1240-04-6
Chemical FormulaC18H23O5S-·K+
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 7 Triethylammonium Salt structure
7
雌酮杂质7 三乙胺盐Estrone Impurity 7 Triethylammonium Salt
Estrone Impurity 7 Triethylammonium Salt
CAS No.21171-73-3
Chemical FormulaC18H22O5S·C6H15N
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 7 structure
7
雌酮杂质7Estrone Impurity 7
Estrone Impurity 7
CAS No.438-67-5
Chemical FormulaC18H21O5S-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 7 Monomer structure
7
雌酮杂质7 单体Estrone Impurity 7 Monomer
Estrone Impurity 7 Monomer
CAS No.481-97-0
Chemical FormulaC18H22O5S
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 8 structure
8
雌酮杂质8Estrone Impurity 8
Estrone Impurity 8
CAS No.3131-23-5
Chemical FormulaC18H22O3
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 9 structure
9
雌酮杂质9Estrone Impurity 9
Estrone Impurity 9
CAS No.58562-33-7
Chemical FormulaC19H24O3
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 10 structure
10
雌酮杂质10Estrone Impurity 10
Estrone Impurity 10
CAS No.1476-78-4
Chemical FormulaC18H22O3
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 11 structure
11
雌酮杂质11Estrone Impurity 11
Estrone Impurity 11
CAS No.2208-12-0
Chemical FormulaC18H20O2
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 12 structure
12
雌酮杂质12Estrone Impurity 12
Estrone Impurity 12
CAS No.1476-34-2
Chemical FormulaC18H20O3
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 13 structure
13
雌酮杂质13Estrone Impurity 13
Estrone Impurity 13
CAS No.858-98-0
Chemical FormulaC25H28O2
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 14 structure
14
雌酮杂质14Estrone Impurity 14
Estrone Impurity 14
CAS No.2911-90-2
Chemical FormulaC18H20O2
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 15 structure
15
雌酮杂质15Estrone Impurity 15
Estrone Impurity 15
CAS No.178971-92-1
Chemical FormulaC23H25N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 16 structure
16
雌酮杂质16Estrone Impurity 16
Estrone Impurity 16
CAS No.488841-24-3
Chemical FormulaC23H25N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 17 structure
17
雌酮杂质17Estrone Impurity 17
Estrone Impurity 17
CAS No.5189-96-8
Chemical FormulaC18H24O3
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 18 structure
18
雌酮杂质18Estrone Impurity 18
Estrone Impurity 18
CAS No.1089-80-1
Chemical FormulaC18H20O2
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 19 structure
19
雌酮杂质19Estrone Impurity 19
Estrone Impurity 19
CAS No.68969-90-4
Chemical FormulaC19H24O2
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 20 structure
20
雌酮杂质20Estrone Impurity 20
Estrone Impurity 20
CAS No.1852-86-4
Chemical FormulaC21H28O2
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 21 structure
21
雌酮杂质21Estrone Impurity 21
Estrone Impurity 21
CAS No.604-82-0
Chemical FormulaC18H22O3
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 22 Sodium Salt structure
22
雌酮杂质22 钠盐Estrone Impurity 22 Sodium Salt
Estrone Impurity 22 Sodium Salt
CAS No.15087-01-1
Chemical FormulaC24H29O8-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 22 structure
22
雌酮杂质22Estrone Impurity 22
Estrone Impurity 22
CAS No.2479-90-5
Chemical FormulaC24H30O8
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 23 structure
23
雌酮杂质23Estrone Impurity 23
Estrone Impurity 23
CAS No.566-65-4
Chemical FormulaC21H32O2
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 24 structure
24
雌酮杂质24Estrone Impurity 24
Estrone Impurity 24
CAS No.58534-72-8
Chemical FormulaC22H26O5
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 25 structure
25
雌酮杂质25Estrone Impurity 25
Estrone Impurity 25
CAS No.900-83-4
Chemical FormulaC20H26O3
Purity>95%询价On request
10mg25mg50mg100mg
Estrone Impurity 26 structure
26
雌酮杂质26Estrone Impurity 26
Estrone Impurity 26
CAS No.690996-26-0
Chemical FormulaC25H28O2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

雌酮 —— 研究文献与合成路线Estrone — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 雌酮 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Estrone. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. A Novel Estrone Degradation Gene Cluster and Catabolic Mechanism in Microbacterium oxydans ML-6
    Miao L, Sun S, Ma T, et al. · Applied and environmental microbiology · 2023 · 被引 18cited 18
  2. Acetylation targets HSD17B4 for degradation via the CMA pathway in response to estrone
    Zhang Y, Xu YY, Yao CB, et al. · Autophagy · 2017 · 被引 37cited 37
  3. Simultaneous Degradation of Estrone, 17β-Estradiol and 17α-Ethinyl Estradiol in an Aqueous UV/H₂O₂ System
    Ma X, Zhang C, Deng J, et al. · International journal of environmental research and public health · 2015 · 被引 21cited 21
  4. Estrone degradation: does organic matter (quality), matter?
    Tan DT, Temme HR, Arnold WA, et al. · Environmental science & technology · 2015 · 被引 18cited 18
  5. Temperature modulates estrone degradation and biological effects of exposure in fathead minnows
    Cox MK, Peterson KN, Tan D, et al. · The Science of the total environment · 2018 · 被引 14cited 14
  6. LINC00173 silence and estrone supply suppress ER+ breast cancer by estrogen receptor α degradation and LITAF activation
    Xie Y, Shan M, Yu J, et al. · Cancer science · 2024 · 被引 6cited 6

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR THE PREPARATION 2-SUBSTITUTED DERIVATIVES OF ESTRONE AND ESTRADIOL
    STOELWINDER JOHANNES, MOERS NICOLAAS ELISABETH CORNELIS · 公开号 US2011152544US2011152544 · 2011
  2. Process for the preparation of estrone and/or estradiolderivatives
    WILLEMS LAMBERTUS GERARDUS MARIA, MAAS HENRICUS JOHANNES FRANCISCUS, MARTIN OSTENDORF · 公开号 ZA200701083ZA200701083 · 2008
  3. PROCESS FOR THE PREPARATION OF ESTRONE AND/OR ESTRADIOL-DERIVATES
    WILLEMS L G M, MAAS H J F, OSTENDORF M · 公开号 KR20070049225KR20070049225 · 2007
  4. PROCESS FOR THE PREPARATION OF ESTRONE AND/OR ESTRADIOL-DERIVATES
    WILLEMS L G M, MAAS H J F, OSTENDORF M · 公开号 MX2007001955MX2007001955 · 2007
  5. METHOD FOR SYNTHESIS OF DIENOGEST FROM ESTRONE-3-METHYLETHER
    DOEHLER THOMAS, WALTHER DIRK, WERNER MICHAEL · 公开号 US2010298585US2010298585 · 2010

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

雌酮 杂质谱研究要点Estrone — impurity profiling notes

下面这些是拿到 雌酮 的 30 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 30 impurity entries for Estrone, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances